More than one reason to rethink the use of peptides in vaccine design
By Anthony W. Purcell, J. McCluskey, J. Rossjohn. Nature reviews. Drug discovery, 2007
848 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/868a37afbe883bfadb4123a0f57f4f63432c7a26
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Tatiana T. Marquez-Lago
- Fuyi Li
- Shutao Mei
- Anthony W. Purcell
- A. Ian Smith
- Tatsuya Akutsu
- Jian Li
- Jiangning Song
Citations in the corpus
- Peptide Vaccine: Progress and Challenges (2014, background): “Allergenicity and/or reactogenicity of carrier molecules themselves increase the complexity of peptide vaccine design.”
- A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction (2020, background): “Understanding which peptides are selected for display in the context of an individual’s HLA type can aid the design of vaccines designed to induce protective or therapeutic immunity towards various pathogens [4, 5].”